Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases

描述（由申请人提供）： 意义：2008 年，美国癌症协会预测，28,660 名男性将死于前列腺癌，使其成为男性癌症死亡的第二大原因。 骨是前列腺癌转移极其常见的部位。 前列腺到骨的转移通过操纵分别称为成骨细胞和破骨细胞的正常骨宿主细胞来促进骨生长和破坏。 结果，患者经常经历剧烈疼痛、自发性骨折和发病，这极大地影响了他的生活质量。 前列腺至骨的转移是无法治愈的，目前的治疗选择是有限的。 为了确定新的治疗靶点，需要全面了解前列腺肿瘤细胞如何与正常骨细胞通讯以诱导骨生长和破坏。 理由：我们已经建立了一种独特的前列腺肿瘤诱导的骨骼生长和破坏的动物模型，可以准确地模拟人类疾病。 我们使用该模型分析了前列腺骨肿瘤中数千个基因的表达，发现几种称为基质金属蛋白酶 (MMP) 的酶以高水平存在（MMP-2、MMP-3、MMP-7、MMP-9 和 MMP-13），并且它们主要由正常骨细胞表达。 MMP 被认为是基质“推土机”，但 PI 使用新兴数据提出了一个新概念，即 MMP 可以通过改变负责前列腺癌诱导骨形成和破坏的关键底物的活性和可用性来促进细胞间通讯，即甲状旁腺相关肽 (PTHrP)、核 kappa B 配体受体激活剂 (RANKL) 和转化生长因子 β (TGF¿)。 基于这些观察，我们假设个体宿主衍生的 MMP 是前列腺肿瘤诱导的骨破坏和骨形成的关键贡献者，因为它们能够调节控制前列腺癌-骨通讯的因子的活性。 方法：在具体目标 1 中，我们将使用 MMP“敲除”动物，使用模拟人类疾病的动物模型来测试这些个体骨源性 MMP 对前列腺肿瘤诱导的骨破坏和形成的贡献。 在具体目标 2 中，我们将确定 MMP 如何通过控制 PTHrP、RANKL 和 TGF 的生物活性和生物利用度来影响前列腺肿瘤诱导的骨变化。 创新和影响：拟议的研究有多项创新； 1）它将首次使用模拟人类疾病的动物模型来探索个体宿主衍生的MMP对前列腺肿瘤诱导的骨形成/破坏的贡献； 2) 它将首次探讨宿主MMP对前列腺肿瘤骨微环境中PTHrP、RANKL和TGF¿的生物活性的影响。 我们提出的研究结果将增强我们对基本肿瘤骨生物学的理解，改变该领域关于 MMP 如何工作的概念，并将揭示可用于治疗患有前列腺骨转移的男性的潜在新治疗靶点。

DESCRIPTION (provided by applicant): Significance: In 2008 the American Cancer Society predicted that 28,660 men will die from prostate cancer making it the second leading cause of cancer death in men. Bone is an extremely common site for prostate cancer metastasis. Prostate to bone metastases promote bone growth and destruction by manipulating normal host cells of the bone known as osteoblasts osteoclasts respectively. As a result, the patient often experiences intense pain, spontaneous fractures and morbidity that dramatically affect his quality of life. Prostate to bone metastases are incurable and the current treatment options are limited. In order to identify new therapeutic targets, a comprehensive understanding of how the prostate tumor cells communicate with the normal bone cells to induce bone growth and destruction is required. Rationale: We have generated a unique animal model of prostate tumor induced bone growth and destruction that accurately mimics the human disease. We have used the model to analyze the expression of thousands of genes in prostate bone tumors and have found that several enzymes known as matrix metalloproteinases (MMPs) are present at high levels (MMP-2, MMP-3, MMP-7, MMP-9 and MMP-13) and that they are predominantly expressed by the normal bone cells. MMPs are considered matrix 'bulldozers' but the PI using emerging data proposes a new concept that MMPs can facilitate cell-cell communication by altering the activity and availability of key substrates responsible for prostate cancer induced bone formation and destruction, namely parathyroid related peptide (PTHrP), receptor activator of nuclear kappa B ligand (RANKL) and transforming growth factor beta (TGF¿). Based on these observations, we hypothesize that individual host derived MMPs are key contributors to prostate tumor induced bone destruction and bone formation by virtue of their ability to regulate the activity of factors that control prostate cancer-bone communication. Approaches: In Specific Aim 1, we will use MMP 'knockout' animals test the contribution of these individual bone derived MMPs to prostate tumor induced bone destruction and formation using animal models that mimic the human disease. In Specific Aim 2, we will determine how MMPs can impact prostate tumor induced changes in the bone by controlling the bioactivity and bioavailability of PTHrP and RANKL and TGF¿. Innovation and Impact: The proposed study has several innovations; 1) It will be the first to explore the contribution of individual host derived MMPs to prostate tumor induced bone formation/destruction using animal models that mimic the human disease; 2) It will be the first to explore the impact of host MMPs on the bioactivity of PTHrP, RANKL and TGF¿ in the prostate tumor-bone microenvironment. The results of our proposed studies will enhance our understanding of basic tumor-bone biology, change the concept of the field as to how MMPs work and will reveal potentially new therapeutic targets that can be used to treat men with prostate to bone metastases.